HSD11B2 and nonpapillary renal cell carcinoma: For instance, Lin et al. described the potential significance of NUDT1 as a prognostic biomarker and therapeutic target in ccRCC40 and Miao et al. reported that HSD11B2 could serve as a potential biomarker and therapeutic target for ccRCC metastasis41.